GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.82
+1.15 (1.67%)
At close: Jun 26, 2026, 4:00 PM EDT
68.70
-1.12 (-1.60%)
After-hours: Jun 26, 2026, 7:58 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.07 billion as of June 26, 2026. Its market cap has increased by 3.31% in one year.
Market Cap
2.07B
Enterprise Value
2.07B
1-Year Change
3.31%
Ranking
Category
Stock Price
$69.82
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.07B, a decrease of -88.42%. That is a compound annual growth rate of -31.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.07B | -44.86% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BillionToOne | 5.31B |
| Sotera Health Company | 4.91B |
| Veracyte | 4.80B |
| RadNet | 4.64B |
| Adaptive Biotechnologies | 3.30B |
| GRAIL | 2.80B |
| NeoGenomics | 1.82B |
| CareDx | 1.49B |